Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Defining the hidden burden of disease in rural communities in Bangladesh, Cambodia and Thailand: a cross-sectional household health survey protocol.

Zhang M. et al, (2024), BMJ Open, 14

Prevalence and Risk Factors of Neonatal Hyperbilirubinemia in a Semi-Rural Area of the Democratic Republic of Congo: A Cohort Study.

Fanello C. et al, (2023), Am J Trop Med Hyg, 109, 965 - 974

Pharmacokinetics of single low dose primaquine in Ugandan and Congolese children with falciparum malaria.

Mukaka M. et al, (2023), EBioMedicine, 96

The heterogeneity of symptom reporting across study sites: a secondary analysis of a randomised placebo-controlled multicentre antimalarial trial.

Thriemer K. et al, (2023), BMC Med Res Methodol, 23

Weekly primaquine for radical cure of patients with Plasmodium vivax malaria and glucose-6-phosphate dehydrogenase deficiency.

Taylor WRJ. et al, (2023), PLoS Negl Trop Dis, 17

BurkHostGEN: a study protocol for evaluating variations in the Burkholderia pseudomallei and host genomes associated with melioidosis infection

Angchagun K. et al, (2023), Wellcome Open Research, 8, 347 - 347

Fever and health-seeking behaviour among migrants living along the Thai-Myanmar border: a mixed-methods study.

Khirikoekkong N. et al, (2023), BMC Infect Dis, 23

Experiences, coping strategies and perspectives of people in Malaysia during the COVID-19 pandemic.

Cheah PK. et al, (2023), BMC Public Health, 23

ACORN (A Clinically-Oriented Antimicrobial Resistance Surveillance Network) II: protocol for case based antimicrobial resistance surveillance

Mo Y. et al, (2023), Wellcome Open Research, 8, 179 - 179

Safety of age-dosed, single low-dose primaquine in children with glucose-6-phosphate dehydrogenase deficiency who are infected with Plasmodium falciparum in Uganda and the Democratic Republic of the Congo: a randomised, double-blind, placebo-controlled, non-inferiority trial.

Taylor WR. et al, (2023), Lancet Infect Dis, 23, 471 - 483

Intravenous Doxycycline, Azithromycin, or Both for Severe Scrub Typhus.

Varghese GM. et al, (2023), N Engl J Med, 388, 792 - 803

ACORN (A Clinically-Oriented Antimicrobial Resistance Surveillance Network) II: protocol for case based antimicrobial resistance surveillance.

Mo Y. et al, (2023), Wellcome open research, 8

ACORN (A Clinically-Oriented Antimicrobial Resistance Surveillance Network) II: protocol for case based antimicrobial resistance surveillance.

Mo Y. et al, (2023), Wellcome Open Res, 8

Antimalarial chemoprophylaxis for forest goers in southeast Asia: an open-label, individually randomised controlled trial.

Tripura R. et al, (2023), Lancet Infect Dis, 23, 81 - 90

BurkHostGEN: a study protocol for evaluating variations in the Burkholderia pseudomallei and host genomes associated with melioidosis infection.

Angchagun K. et al, (2023), Wellcome Open Res, 8

Investigating secondary use of clinical research data: a protocol for a mixed methods study (Preprint)

Waithira N. et al, (2022), JMIR Research Protocols

Understanding the extent and impact of secondary use of clinical research data with a focus on Low and Middle Income Countries: a cross sectional mixed methods study (REUSE) (Preprint)

Waithira N. et al, (2022)

Facilitating Safe Discharge Through Predicting Disease Progression in Moderate Coronavirus Disease 2019 (COVID-19): A Prospective Cohort Study to Develop and Validate a Clinical Prediction Model in Resource-Limited Settings.

Chandna A. et al, (2022), Clin Infect Dis, 75, e368 - e379

Triple therapy with artemether-lumefantrine plus amodiaquine versus artemether-lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trial.

Peto TJ. et al, (2022), Lancet Infect Dis, 22, 867 - 878

Defining the burden of febrile illness in rural South and Southeast Asia: an open letter to announce the launch of the Rural Febrile Illness project

Chandna A. et al, (2022), Wellcome Open Research, 6, 64 - 64

Load More

Include forthcoming?